Trevi Therapeutics Inc (NAS:TRVI)
$ 4.27 0.06 (1.43%) Market Cap: 376.23 Mil Enterprise Value: 293.08 Mil PE Ratio: 0 PB Ratio: 5.38 GF Score: 40/100

Q4 2021 Trevi Therapeutics Inc Earnings Call Transcript

Mar 17, 2022 / 08:30PM GMT
Release Date Price: $1.53 (+4.79%)
Operator

Good afternoon, and welcome to the Trevi Therapeutics Q4 and Year-end 2021 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

Various remarks that management makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent annual report on Form 10-K, which the company filed with the SEC this afternoon.

In addition, any forward-looking statements represent the company's views only as of today and should not be relied upon as representing the company's views of any subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so even if its views change.

I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot